News by ImmuneWatch

  • ImmuneWatch, Quantoom Biosciences (Univercells) and UAntwerp join forces to explore new in vitro and in silico assays that predict T cell responses in vaccines

    Wednesday March 29th 2023

  • ImmuneWatch receives Antwerp Innovation grant to accelerate vaccine development with AI

    Monday March 27th 2023

  • ImmuneWatch secures a VLAIO grant to tailor their technology to vaccine developers

    Monday September 12th 2022